Clinical trials: Normal Drug Tolerance

Atopic Dermatitis

Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

• Terminated
• Age: 3 to 12 years
• Results posted

Atopic dermatitis is one of the most frequent skin diseases. The disease is often worst during winter months when the skin is drier. Mild to moderate cases of atopic dermatitis are often controlled by a moisturizer alone.

Trial name

NCT00931411

Testing

Formulation 609580 20, Formulation 609209 (Lipikar Baume)

Where

5 sites in Canada

Volunteers

73 people

Sponsor

Cosmetique Active International